» Articles » PMID: 25163793

Non-steroidal Anti-inflammatory Drug Use in Chronic Pain Conditions with Special Emphasis on the Elderly and Patients with Relevant Comorbidities: Management and Mitigation of Risks and Adverse Effects

Overview
Specialty Pharmacology
Date 2014 Aug 29
PMID 25163793
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most frequently used drugs, and this widespread use is complicated by safety issues.

Method: A Literature review was conducted.

Results: NSAIDs are a leading cause of drug-related morbidity, especially in the elderly and patients with comorbidities. Most adverse effects are related to generalized inhibition of the major targets of NSAIDs: cyclooxygenases I and II. These enzymes are not only involved in pain and inflammation pathogenesis but are also required in the gastrointestinal (GI) tract for mucosal protection and gut motility, and in the kidneys for functional integrity. Thus, the mechanisms of NSAID toxicity are well understood, but the consequences are largely uncontrolled in clinical practice. GI ulcers, including bleeding ulcers, may occur in several percent of all chronic unprotected, high-dose NSAID users. Renal side effects may precipitate renal failure, resulting in acute dialysis and chronic retention. This includes sodium retention, resulting in arterial hypertension, heart failure, and atherosclerotic events. Cardiovascular risk may be tripled by chronic high-dose NSAID use in long-term clinical trials though "real-life studies" indicate lower risk ratios. Off-target side effects include allergic reactions, drug-induced liver injury, and central nervous system effects.

Conclusions: Management of pain and inflammation must consider those risks and find alternative drugs or approaches to limit the negative impact of NSAIDs on mortality and morbidity. Alternative drugs, low-dose/short-term use, but especially non-pharmacologic approaches, such as physiotherapy, exercise, neurophysiologic measures, and local therapies, need to be further utilized. The appalling equation "less pain-more deaths/morbidity" ultimately necessitates treatment optimization in the individual patient.

Citing Articles

Regular Use of Oral Nonsteroidal Anti-inflammatory Drugs in a Population of Polish Seniors: Findings from the PolSenior2 Cross-Sectional Survey.

Wierzba K, Chmielewski M, Bleszynska-Marunowska E, Jagiello K, Wierucki L, Zdrojewski T Drugs Aging. 2025; 42(3):245-255.

PMID: 39873974 DOI: 10.1007/s40266-025-01180-x.


Exploring the impact of perioperative analgesia on postoperative chronic analgesic prescriptions in patients with lung cancer undergoing minimally invasive thoracic surgery: A retrospective observational study.

Yabuki S, Kaiho Y, Tarasawa K, Ikumi S, Iwasaki Y, Imaizumi T Eur J Pain. 2024; 29(2):e4774.

PMID: 39731216 PMC: 11680971. DOI: 10.1002/ejp.4774.


Development of a set of indicators for the quality of chronic pain management in Chinese community-dwelling older adults: a Delphi study.

Li X, Zou J, Hu Q, Li R, Gao J, Xu L BMC Geriatr. 2024; 24(1):1041.

PMID: 39731049 PMC: 11674520. DOI: 10.1186/s12877-024-05638-2.


The Therapeutic Management of Chemical and Herbal Medications on Uric Acid Levels and Gout: Modern and Traditional Wisdom.

Lin Z, Gupta J, Maqbool M, Kumar K, Sharma A, Wahi N Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598418 PMC: 11597706. DOI: 10.3390/ph17111507.


Hypertensive Encephalopathy Triggered by Indomethacin Use.

Plitman J, Raco V, Wu P Clin Case Rep. 2024; 12(11):e9604.

PMID: 39568533 PMC: 11576139. DOI: 10.1002/ccr3.9604.


References
1.
Ingvarsson T, Hagglund G, Lohmander L . Prevalence of hip osteoarthritis in Iceland. Ann Rheum Dis. 1999; 58(4):201-7. PMC: 1752858. DOI: 10.1136/ard.58.4.201. View

2.
Tielemans M, van Rossum L, Eikendal T, Focks J, Laheij R, J B M J Jansen . Gastrointestinal symptoms in NSAID users in an 'average risk population': results of a large population-based study in randomly selected Dutch inhabitants. Int J Clin Pract. 2014; 68(4):512-9. DOI: 10.1111/ijcp.12346. View

3.
Andrade S, Martinez C, Walker A . Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol. 1999; 51(12):1357-65. DOI: 10.1016/s0895-4356(98)00076-6. View

4.
Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

5.
Wang X, Tian H, Yang H, Wanyan P, Peng Y . Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis. Eur J Gastroenterol Hepatol. 2011; 23(10):876-80. DOI: 10.1097/MEG.0b013e328349de81. View